One‐Dose Bioorthogonal Gadolinium Nanoprobes for Prolonged Radiosensitization of Tumor
Small · 2025
DOI: 10.1002/smll.202500504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Dinghua Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nan…. Hauptthemen laut MEDLINE: Gadolinium, Radiation-Sensitizing Agents, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Developing effective radiotherapy is impeded by tumor radioresistance, imprecise treatment, and the need for accurate imaging. Herein, a multifunctional gadolinium‐based nanoprobe (GBD) is presented, integrating bioorthogonal click chemistry and theranostics to enhance tumor retention, magnetic resonance imaging (MRI) contrast, and radiosensitivity. GBD synthesis involved biomimetic mineralization of bovine serum albumin (BSA) with gadolinium ions to form nanoparticles (GB), followed by conjugation with dibenzocyclooctyne (DBCO). The optimized GBD exhibited an elevated longitudinal relaxivity (r1) of 25.54 mM −1 s −1 , which represented a 6.7‐fold enhancement compared to the clinical MRI contrast agent magnevist (Gd‐DTPA, 3.81 mM −1 s −1 ). Notably, the application of bioorthogonal click chemistry enhanced the affinity and retention of GBD within tumor cells modified to express azide as an artificial receptor. This novel strategy enhanced tumor retention up to 16 days postinjection, outperforming DBCO‐modified small molecule gadolinium (Gd‐DBCO) with less than 1‐day retention. Such prolonged retention facilitated continuous radiosensitization throughout the radiotherapy course, negating the need for multiple injections, and substantially boosted the effectiveness of radiotherapy. This study demonstrates the transformative potential of combining bioorthogonal click chemistry with nanotechnology in radiotherapy, offering a precise tumor targeting platform, real‐time monitoring, and improved treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai, 200065, Ch…
- Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
- Shanghai Research Institute for Intelligent Autonomous Systems, Tongji University, Shanghai, 201210, China.
ORCID-Profile: Weitao Yang, Bingbo Zhang
Förderung
- National Key Research and Development Project
- National Natural Science Foundation of China
Zitieren
APA
Liu, D., Wang, H., Yang, W., Bai, Y., Wu, Z., Cui, T., Bian, K., Yi, J., Shao, C., & Zhang, B. (2025). One‐Dose Bioorthogonal Gadolinium Nanoprobes for Prolonged Radiosensitization of Tumor. Small. https://doi.org/10.1002/smll.202500504
Vancouver
Liu D, Wang H, Yang W, Bai Y, Wu Z, Cui T, et al. One‐Dose Bioorthogonal Gadolinium Nanoprobes for Prolonged Radiosensitization of Tumor. Small. 2025. doi:10.1002/smll.202500504
BibTeX
@article{Liu2025,
author = {Liu, Dinghua and Wang, Hui and Yang, Weitao and Bai, Yang and Wu, Zhuoyao and Cui, Tianming and Bian, Kexin and Yi, Jinyan and Shao, Chunlin and Zhang, Bingbo},
title = {One‐Dose Bioorthogonal Gadolinium Nanoprobes for Prolonged Radiosensitization of Tumor},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202500504}
}
EUVIMED